Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

FDA updates labeling for NUCYNTA

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 3
  • 0 comments

Labeling changes approved for COLLEGIUM PHARM INC. Active ingredient: TAPENTADOL HYDROCHLORIDE. Decision date: 12/22/2025

Comment Full text

FDA updates labeling for DSUVIA

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 14
  • 0 comments

Labeling changes approved for VERTICAL PHARMS. Active ingredient: SUFENTANIL CITRATE. Decision date: 12/22/2025

Comment Full text

FDA updates labeling for ROXYBOND

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 12
  • 0 comments

Labeling changes approved for PROTEGA PHARMS. Active ingredient: OXYCODONE HYDROCHLORIDE. Decision date: 12/22/2025

Comment Full text

FDA updates labeling for SUBLOCADE

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 9
  • 0 comments

Labeling changes approved for INDIVIOR. Active ingredient: BUPRENORPHINE. Decision date: 12/22/2025

Comment Full text

FDA updates labeling for OXYCODONE AND ACETAMINOPHEN

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 9
  • 0 comments

Labeling changes approved for ASCENT PHARMS INC. Active ingredient: ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE. Decision date: 12/22/2025

Comment Full text

FDA updates labeling for MEPERIDINE HYDROCHLORIDE PRESERVATIVE FREE

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 9
  • 0 comments

Labeling changes approved for INTL MEDICATION. Active ingredient: MEPERIDINE HYDROCHLORIDE. Decision date: 12/22/2025

Comment Full text

FDA updates labeling for ACETAMINOPHEN AND CODEINE PHOSPHATE

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 8
  • 0 comments

Labeling changes approved for FOSUN PHARMA. Active ingredient: ACETAMINOPHEN; CODEINE PHOSPHATE. Decision date: 12/22/2025

Comment Full text

FDA updates labeling for ACETAMINOPHEN AND CODEINE PHOSPHATE

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 7
  • 0 comments

Labeling changes approved for FOSUN PHARMA. Active ingredient: ACETAMINOPHEN; CODEINE PHOSPHATE. Decision date: 12/22/2025

Comment Full text

FDA updates labeling for MORPHINE SULFATE

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 8
  • 0 comments

Labeling changes approved for ACTAVIS ELIZABETH. Active ingredient: MORPHINE SULFATE. Decision date: 12/22/2025

Comment Full text

FDA updates labeling for PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 10
  • 0 comments

Labeling changes approved for CHARTWELL RX. Active ingredient: CODEINE PHOSPHATE; PROMETHAZINE HYDROCHLORIDE. Decision date: 12/22/2025

Comment Full text
  • Previous
  • 14
  • 15
  • 16
  • 17
  • 18
  • Next

Search

News categories

  • Technical Exchange News(10841)
  • Event(2204)
  • SEC News(187799)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124251)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin